To enhance the power to identify additional CRC risk loci, we conducted a meta-analysis of three GWAS from the UK which included a total of 3,334 affected individuals (cases) and 4,628 controls followed by multiple validation analyses including a total of 18,095 cases and 20,197 controls. We identified associations at four new CRC risk loci: 1q41 (rs6691170, odds ratio (OR) = 1.06, P = 9.55 × 10 −10 and rs6687758, OR = 1.09, P = 2.27 × 10 −9 ), 3q26.2 (rs10936599, OR = 0.93, P = 3.39 × 10 −8 ), 12q13.13 (rs11169552, OR = 0.92, P = 1.89 × 10 −10 and rs7136702, OR = 1.06, P = 4.02 × 10 −8 ) and 20q13.33 (rs4925386, OR = 0.93, P = 1.89 × 10 −10 ). In addition to identifying new CRC risk loci, this analysis provides evidence that additional CRC-associated variants of similar effect size remain to be discovered.
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VOLUME 42 | NUMBER 11 | NOVEMBER 2010 Nature GeNetics l e t t e r S publicly available control data to remove SNPs and individuals that fell below pre-determined quality control standards (Online Methods), we examined associations between genotype and CRC status. A quantilequantile plot showed no evidence of systematic inflation of the allelic test statistic (genomic control inflation factor (λ gc ) = 1.018). No individual SNP showed association with CRC under dominant, additive or recessive models at genome-wide significance (set at P ≤ 1.0 × 10 −7 based on a Bonferroni correction). This was not unexpected given the power of the VQ58 dataset to detect associations of the magnitudes found in our previous analyses of the UK and Scottish GWAS 2 . We therefore proceeded directly to a combined analysis of UK1 (CORGI) and Scotland1 (COGS) and VQ58 (Supplementary Table 1 ). Quality control measures were standardized throughout the sample sets. We used principal components analysis (PCA) to examine whether there was evidence of distinct genetic subgroups within the three GWAS. After removal of 88 outliers and 6 duplicate samples, the Scottish and UK (UK1 (CORGI) and VQ58) samples essentially clustered together, with minor variation in the first component reflecting the known north-west to south-east cline in the UK (Supplementary Fig. 1 ).
The UK1 and Scotland1 samples had previously been genotyped using Illumina Hap550 arrays. We therefore imputed genotype probabilities in the VICTOR and QUASAR2 samples at SNPs not present on the Illumina Hap300 and Hap370 arrays. Of the SNPs we imputed, 94,867 out of 214,649 passed our threshold of ≤5% missing genotypes and an information score of ≥0.5. We then conducted a meta-analysis of the three datasets (Supplementary Table 1 ) using the MantelHaenszel method under both fixed-and random-effects models. Only one SNP (rs4939827 on chromosome (chr.) 18q21.1), which was previously shown to be associated with CRC risk [3] [4] [5] , achieved genome-wide significance for association.
At this stage, we considered whether to include data we had generated from two additional large UK case-control sets in our metaanalysis: UK2 (NSCCG) (comprising 2,854 cases and 2,822 controls) and Scotland2 (SOCCS) (comprising 2,024 cases and 2,092 controls) (Supplementary Table 1 ). These additional samples had been genotyped at 55,000 SNPs with the strongest evidence of association from a meta-analysis of the UK1 (CORGI) and Scotland1 (COGS) GWAS 2 . If we were to include these extra data, essentially we had to weigh two factors: (i) the extra power afforded by including UK2 (NSCCG) and Scotland2 (SOCCS) data compared to (ii) the probability that a true CRC SNP had not been taken forward into the top 55,000 SNPs from the UK1 and Scotland1 meta-analysis but did make it into a smaller set of top SNPs in a VQ58, UK1 and Scotland1 meta-analysis. Power calculations showed that, except for rare alleles with small effects for which the power of detection was in any event low, the extra power provided by the UK2 and Scotland2 samples more than compensated for the loss of a few true disease-associated SNPs that would not have reached the significance threshold for genotyping in UK2 and Scotland2 (Supplementary Fig. 2) .
We therefore undertook a meta-analysis of VQ58, UK1 (CORGI), Scotland1 (COGS), UK2 (NSCCG) and Scotland2 (SOCCS) (Fig. 1) . Seven SNPs achieved significant associations (P < 10 −7 ) in this analysis. All these SNPs had previously been shown to be associated with CRC risk. After exclusion of SNPs in strong pairwise linkage disequilibrium (LD) (r 2 > 0.7), we selected seven SNPs (rs11805285, rs6687758, rs6691170, rs10936599, rs7136702, rs11169552 and rs4925386) with nominal associations at P < 5.0 × 10 −5 . All of these SNPs had been genotyped, rather than imputed, in the VQ dataset. These seven SNPs underwent validation testing in 9,883 CRC cases and 10,655 controls from six independent, northern European case-control series (COIN (NBS), Helsinki, UK3 (NSCCG), UK4 (CORGI2BCD), Scotland3 (SOCCS) and Cambridge; Supplementary Table 1) . This threshold for follow up did not exclude the possibility that other SNPs represented genuine association signals, but was simply a pragmatic strategy for prioritizing replication. After further genotyping, significant associations were confirmed for six SNPs mapping to four loci: rs6687758 (P = 2.27 × 10 −9 ) and rs6691170 (P = 9.55 × 10 −10 ) at 1q41; rs10936599 (P = 3.39 × 10 −8 ) at 3q36.2, rs7136702 (P = 4.02 × 10 −8 ) and rs11169552 (P = 1.89 × 10 −10 ) at 12q13.13; and rs4925386 (P = 1.89 × 10 −10 ) at 20q13.3 (Fig. 2 , Table 1 and Supplementary Table 2 ). There was no significant between-study heterogeneity for these SNP associations (P het > 0.05 for all SNPs; Table 1), and no SNP showed any evidence of association with age or sex in any dataset (P > 0.05).
rs6691170 (on chr. 1 at location 220,112,069) and rs6687758 (on chr. 1 at 220,231,571) lie 125 kb from each other on chromosome 1q41 ( Table 1 ). The region containing these two SNPs (Fig. 3) is flanked by recombination hotspots close to rs3003888 (on chr. 1 at 220,049,548) and rs6687797 (on chr. 1 at 220,296,043). Between these sites, LD relationships are complex and LD blocks are not easily defined, although a minor recombination hotspot exists on chr. 1 at 220,137,516 between rs6691170 and rs66867758. rs6691170 and rs66867758, respectively, lie 250 kb and 125 kb upstream of DUSP10, which encodes a dualspecificity phosphatase that inactivates p38 and SAPK (JNK). The region otherwise contains few genes but does contain several spliced ESTs. In the UK datasets, rs6691170 and rs6687758 were in modest pairwise LD (r 2 = 0.22 and D′ = 0.71), raising the possibility that these SNPs may represent independent signals of association. We assessed this using multiple logistic regression analysis stratified by sample series in which genotypes at one SNP were assessed conditional on Figure 1 Overall study design. l e t t e r S those at the other SNP. We found that rs6691170 had an OR of 1.07 (P = 6.15 × 10 −5 ), and rs6687758 had an OR of 1.06 (P = 1.92 × 10 −4 ). Individuals with the high-risk haplotype (TG) at rs6691170 and rs6687758 had a 1.15-fold increased risk of CRC compared to those individuals with the low-risk haplotype (GA) (P = 5.39 × 10 −8 ).
rs10936599 (on chr. 3 at 170,974,795) is flanked by recombination hotspots at chr. 3 position 170,837,364 and chr. 3 position 171,082,143 (Fig. 3) . rs10936599 lies at 3q26.2 within MYNN (the myoneurin gene), which encodes a zinc finger protein of unknown function that is expressed principally in muscle. rs10936599 is also close to the actin-related protein M1 locus.
rs7136702 (on chr. 12 at 49,166,483) and rs11169552 (on chr. 12 at 49,441,930) lie about 275 kb apart within what is essentially a large, poorly-defined haplotype block (Fig. 3) composed of a set of smaller blocks but with considerable long-range LD between markers (chr. 12 spanning 48,658,293-49,505,968). rs7136702 is just telomeric to the myeloproliferative oncogene binding-protein gene LARP4 and 30 kb proximal to DIP2 (encoding disco-interacting protein 2B), which may have a role in determining epithelial cell fate. rs11169552 is just telomeric to DIP2B and proximal to ATF1 (encoding activating transcription factor 1). ATF1 is the 3′ partner in the recurrent translocations with EWSR1 (22q12) that contribute to the development of soft-tissue clear-cell sarcomas 6 . rs7136702 and rs11169552 map close to a known chromosomal fragile site, but we found that colorectal tumors rarely show somatic chromosomal breakpoints at this site 7 . rs7136702 and rs11169552 are not strongly correlated (r 2 = 0.11 and D′ = 0.76 in the UK samples). We therefore tested independence of these signals using conditioned logistic regression analysis just as we did for the chromosome 1 signals. In this combined analysis, the rs11169552 signal nearly retained global significance (OR = 0.91, P = 4.33 × 10 −7 ), whereas the strength of association at rs7136702 was reduced (OR = 1.06, P = 4.34 × 10 −4 ). Individuals with the high-risk haplotype (TC) at rs7136702 and rs11169552 had a 1.14-fold increased risk of CRC compared with the low-risk haplotype (CT) (P = 6.90 × 10 −8 ).
rs4925386 (on chr. 20 at 60,354,439) is within a very small haplotype block (on chr. 20 spanning 60,330,882-60,355,038), although 
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it shows moderate LD with distal markers outside the block (Fig. 3) . rs4925386 lies within LAMA5 (encoding large laminin A5), which is required for the production of noggin, a secreted BMP antagonist. It is notable that other BMP pathway SNPs are likely to be involved in CRC predisposition 2 . rs4935386 is in moderate to strong LD (r 2 > 0.5) with four non-synonymous LAMA5 SNPs which lead to the substitutions p.Ala1908Thr, p.Arg2226His, p.Asp2062Asn and p.Val1900Met, although all of these alterations are predicted to be benign.
For both 1q41 and 12q13.12, the two signals, if independent, might have resulted from two causal variants or from a single causal variant strongly associated with disease and correlated with both SNPs in the region. For each region, we addressed the latter possibility by imputing SNPs from the HapMap2 European CEU samples between the flanking recombination hotspots. We conducted logistic regression analysis of the GWAS and UK2 (NSCCG) and Scotland2 (SOCCS) datasets, conditioning on the genotypes at each of the two identified SNPs. Although a small number of imputed SNPs from 12q13.12 had a stronger predicted association than the genotyped SNPs (Supplementary Fig. 3 ), no single imputed SNP was able to account for the dual signals in either the 1q41 or 12q13.12 region.
To explore whether any of these newly discovered CRC associations resulted from cis-acting regulatory elements, we examined whether any of the six SNPs tagged reported expression quantitative trait loci (eQTLs) for nearby genes. Although four SNPs had no association with known eQTLs, rs7136702 was in moderate to strong LD (r 2 = 0.47 to r 2 = 0.61 and D′ = 0.80 to D′ = 0.84) with four SNPs (rs11169520, rs11169524, rs3742062 and rs2280503) that have previously been associated with DIP2B expression in lymphoblastoid cell lines 8 . Furthermore, rs492536 was in moderate to strong LD (r 2 = 0.61, D′ = 0.78) with rs13043313, an eQTL for LAMA5 expression in the liver 7 .
Using a case-only design, we searched for pairwise gene-gene interactions between the six new CRC susceptibility SNPs and also between these six SNPs and the ten previously identified risk SNPs (rs6983267, rs16892766, rs10795668, rs3802842, rs4444235, rs4779584, rs9929218, rs4939827, rs10411210 and rs961253) 2 . Although there was suggestive evidence of epistasis between rs6687758 and rs7136702 (P = 7.70 × 10 −4 ), this evidence did not meet the threshold for significance after adjustment for 120 comparisons (P = 4.2 × 10 −4 ). There was no evidence to suggest any functional relationships between genes close to these SNPs. No other evidence of gene-gene interactions was found (data not shown).
We identified four new CRC risk loci, none of which maps to previously reported cancer predisposition genes of high or low penetrance. At two of these loci, there exists the possibility that two SNPs independently predict risk. Our study illustrates other general issues that currently affect large-scale studies to identify common predisposition alleles. Allelic ORs were less than 1.10 for each of the CRC SNPs we identified. Power to detect the effects of such loci was therefore modest, with the likelihood of discovery being highly sensitive to small chance differences in genotype frequencies, especially in the three GWAS datasets. Therefore, many more CRC loci of similar effect size may exist. Although the new CRC risk alleles we have identified collectively account for ~1.5% of the familial CRC risk, in concert with other alleles they have the potential to substantially influence disease risk and thus have an application to risk stratification at a population level. Finally, the loci we identified are likely to provide fresh insights into the etiological basis of CRC. l e t t e r S Institute of Cancer Research and local collaborators: subject recruitment and sample acquisition to NSCCG were undertaken by S.P. The coordination of sample preparation and genotyping was performed by P.B. Sample preparation and genotyping were performed by A.M.P. and B.O.
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